Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase - PubMed (original) (raw)
Comparative Study
. 2009 May;91(5):1857-63.
doi: 10.1016/j.fertnstert.2008.02.120. Epub 2008 Jun 6.
Affiliations
- PMID: 18538325
- DOI: 10.1016/j.fertnstert.2008.02.120
Free article
Comparative Study
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase
Francesca Sagnella et al. Fertil Steril. 2009 May.
Free article
Abstract
Objective: To evaluate the effects of the GnRH antagonist cetrorelix on the gonadal axis in patients with polycystic ovary syndrome (PCOS).
Design: Observational clinical study.
Setting: Academic research center.
Patient(s): Ten patients with PCOS and 10 controls with normal ovulation.
Intervention(s): Patients received a daily cetrorelix injection (0.25 mg SC at 9:00 am) for 6 days, starting from day 3 of the menstrual cycle.
Main outcome measure(s): Serum gonadotropin, E(2), T, 17-OH-P, and androstenedione plasma levels were evaluated at baseline and at 12 and 24 hours after each daily injection. These hormones were also assayed at days 10, 12, and 14 of the menstrual cycle.
Result(s): We observed in patients with PCOS a significantly higher suppression of FSH and LH for the entire length of therapy; LH recovery secretion was significantly higher in the PCOS group. Regarding androgens, we found a greater suppression of T. Androstenedione and 17-OH-P showed a trend toward a higher suppression in PCOS.
Conclusion(s): Gonadotropin and androgen suppression by GnRH antagonist is more effective in PCOS than in controls, suggesting a higher sensitivity of GnRH receptors in PCOS to this drug.
Similar articles
- Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C. Filicori M, et al. J Clin Endocrinol Metab. 1988 Feb;66(2):327-33. doi: 10.1210/jcem-66-2-327. J Clin Endocrinol Metab. 1988. PMID: 3123511 - Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, Marshall JC. Eagleson CA, et al. J Clin Endocrinol Metab. 2000 Nov;85(11):4047-52. doi: 10.1210/jcem.85.11.6992. J Clin Endocrinol Metab. 2000. PMID: 11095431 Clinical Trial. - Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.
Hayes FJ, Taylor AE, Martin KA, Hall JE. Hayes FJ, et al. J Clin Endocrinol Metab. 1998 Jul;83(7):2343-9. doi: 10.1210/jcem.83.7.4925. J Clin Endocrinol Metab. 1998. PMID: 9661606 Clinical Trial. - Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
McCartney CR, Eagleson CA, Marshall JC. McCartney CR, et al. Semin Reprod Med. 2002 Nov;20(4):317-26. doi: 10.1055/s-2002-36706. Semin Reprod Med. 2002. PMID: 12536355 Review. - Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome.
Barontini M, García-Rudaz MC, Veldhuis JD. Barontini M, et al. Arch Med Res. 2001 Nov-Dec;32(6):544-52. doi: 10.1016/s0188-4409(01)00325-3. Arch Med Res. 2001. PMID: 11750729 Review.
Cited by
- Troxerutin protects against DHT-induced polycystic ovary syndrome in rats.
Gao Z, Ma X, Liu J, Ge Y, Wang L, Fu P, Liu Z, Yao R, Yan X. Gao Z, et al. J Ovarian Res. 2020 Sep 13;13(1):106. doi: 10.1186/s13048-020-00701-z. J Ovarian Res. 2020. PMID: 32921318 Free PMC article. - GnRH pulsatility, the pituitary response and reproductive dysfunction.
Tsutsumi R, Webster NJ. Tsutsumi R, et al. Endocr J. 2009;56(6):729-37. doi: 10.1507/endocrj.k09e-185. Epub 2009 Jul 17. Endocr J. 2009. PMID: 19609045 Free PMC article. Review. - Gonadotropin-Releasing Hormone Analogue Stimulation Test Versus Venous Sampling in Postmenopausal Hyperandrogenism.
Tng EL, Tan JMM. Tng EL, et al. J Endocr Soc. 2020 Nov 5;5(1):bvaa172. doi: 10.1210/jendso/bvaa172. eCollection 2021 Jan 1. J Endocr Soc. 2020. PMID: 33324863 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical